Samsung Biologics Co.,Ltd. (KRX:207940)

Samsung Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	86,903,453	67,544,125	54,092,240	58,433,854	59,746,994	54,652,290
Market Cap Growth	23.83%	24.87%	-7.43%	-2.20%	9.32%	90.76%
Enterprise Value	86,676,642	67,525,830	54,470,491	57,778,382	59,669,231	54,358,190
Last Close Price	1877331.38	1459121.61	1168527.32	1262317.01	1373802.92	1256656.94
PE Ratio	67.58	62.35	63.07	73.22	151.80	226.80
Forward PE	45.35	62.18	60.08	82.37	112.20	-
PS Ratio	17.27	14.85	14.64	19.47	38.10	46.92
PB Ratio	7.49	6.19	5.50	6.50	11.97	11.88
P/TBV Ratio	9.76	8.52	8.23	10.14	12.05	11.95
P/FCF Ratio	190.37	189.90	80.60	-	1235.91	875.48
P/OCF Ratio	37.20	40.71	32.46	61.31	131.43	270.44
PEG Ratio	2.07	3.19	3.45	3.32	3.45	-
EV/Sales Ratio	17.23	14.85	14.74	19.25	38.05	46.67
EV/EBITDA Ratio	37.78	35.19	33.97	44.72	85.35	124.54
EV/EBIT Ratio	52.69	51.15	48.91	58.74	111.05	185.66
EV/FCF Ratio	189.87	189.85	81.16	-	1234.30	870.77
Debt / Equity Ratio	0.12	0.14	0.19	0.28	0.26	0.17
Debt / EBITDA Ratio	0.62	0.77	1.19	1.95	1.85	1.80
Debt / FCF Ratio	3.11	4.18	2.85	-	26.74	12.57
Asset Turnover	0.30	0.27	0.23	0.24	0.22	0.19
Inventory Turnover	0.82	0.83	0.76	0.91	1.02	1.37
Quick Ratio	0.45	0.35	0.50	0.76	1.24	1.45
Current Ratio	1.57	1.43	1.33	1.54	2.55	2.97
Return on Equity (ROE)	11.73%	10.45%	9.12%	11.42%	8.21%	5.38%
Return on Assets (ROA)	5.96%	4.94%	4.27%	5.01%	4.67%	2.97%
Return on Capital (ROIC)	8.12%	6.84%	5.99%	6.91%	5.76%	3.52%
Return on Capital Employed (ROCE)	11.50%	9.80%	9.40%	7.90%	7.80%	5.00%
Earnings Yield	1.48%	1.60%	1.59%	1.37%	0.66%	0.44%
FCF Yield	0.53%	0.53%	1.24%	-0.01%	0.08%	0.11%
Buyback Yield / Dilution	-	-	-1.95%	-5.51%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.